{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05423197",
            "orgStudyIdInfo": {
                "id": "IRB-63234"
            },
            "secondaryIdInfos": [
                {
                    "id": "ENT0095",
                    "type": "OTHER",
                    "domain": "Stanford OnCore"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma",
            "officialTitle": "Phase II Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-evaluating-zr-panitumumab-for-assessment-of-suspected-metastatic-lesions-on-fdg-pet-ct-in-head-and-neck-squamous-cell-carcinoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-14",
            "studyFirstSubmitQcDate": "2022-06-14",
            "studyFirstPostDateStruct": {
                "date": "2022-06-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Andrei Iagaru",
                "investigatorTitle": "Professor of Radiology (Nuclear Medicine)",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Andrei Iagaru",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine the diagnostic utility of 89Zr-panitumumab to identify metastatic lesion(s) in subjects with head and neck squamous cell carcinoma (HNSCC).",
            "detailedDescription": "PRIMARY OBJECTIVE(S):\n\n- Determine the sensitivity and specificity of 89Zr-panitumumab for the detection of suspected metastatic lesions\n\nSECONDARY OBJECTIVE(S):\n\n- Compare sensitivity and specificity of 18F-FDG-PET/CT and 89Zr-panitumumab-PET/CT for detection of suspected metastatic lesions"
        },
        "conditionsModule": {
            "conditions": [
                "Head-and-neck Squamous Cell Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "panitumumab 30 mg",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects will be given a 30mg of panitumumab",
                    "interventionNames": [
                        "Drug: Panitumumab"
                    ]
                },
                {
                    "label": "89Zr-panitumumab IV",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will be given 89Zr-panitumumab IV",
                    "interventionNames": [
                        "Drug: 89Zr-panitumumab IV"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "89Zr-panitumumab IV",
                    "description": "Subjects will be given a bolus of 1.0 mCi (range 0.8 - 1.2 mCi) of 89Zr-panitumumab before undergoing further standard of care diagnostic evaluation of the lesions",
                    "armGroupLabels": [
                        "89Zr-panitumumab IV"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Panitumumab",
                    "description": "Panitumumab 30mg will be given orally",
                    "armGroupLabels": [
                        "panitumumab 30 mg"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Sensitivity and Specificity of 89Zr-panitumumab",
                    "description": "The total number of head and neck squamous cell carcinoma-involved incidental lesions will be determined and correlated to the radiologically suspicious lesions identified by 89Zr-panitumumab using PET/CT imaging.",
                    "timeFrame": "Up to 1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Sensitivity and Specificity 89Zr-panitumumab compared to standard of care 18F-FDG PET/CT imaging",
                    "description": "The total number of head and neck squamous cell carcinoma-involved incidental lesions will be determined and correlated to the radiologically suspicious lesions identified by 18F-FDG using PET/CT imaging. The specificity and sensitivity of 89Zr-panitumumab will be compared to the specificity and sensitivity of 18F-FDG for identification of metastatic lesions.",
                    "timeFrame": "Up to 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 19 years.\n* Biopsy confirmed diagnosis of squamous cell carcinoma of the head and neck.\n* Subjects diagnosed with any T stage, any subsite within the head and neck. Subjects with recurrent disease or a new primary will be allowed.\n* Must have standard of care 18F-FDG-PET/CT scan \u2264 30 days of Day 0 with suspected metastatic lesions.\n* Have acceptable hematological status, coagulation status, kidney function, and liver function including the following clinical results:\n\n  * Hemoglobin \u2265 9gm/dL\n  * White blood cell count \\> 3000/mm3\n  * Platelet count \u2265 100,000/mm3\n  * Serum creatinine \u2264 1.5 times upper reference range\n  * PTT = 11.5 - 14.4 seconds\n  * INR = 0.9 - 1.2\n\nExclusion Criteria:\n\n* Myocardial infarction (MI); cerebrovascular accident (CVA); uncontrolled congestive heart failure (CHF); significant liver disease; or unstable angina within 6 months prior to enrollment\n* History of infusion reactions to other monoclonal antibody therapies\n* Pregnant or breastfeeding\n* Magnesium or potassium lower than the normal institutional values\n* Subjects receiving Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents\n* Subjects with a history or evidence of interstitial pneumonitis or pulmonary fibrosis\n* Severe renal disease or anuria\n* Known hypersensitivity to deferoxamine or any of its components",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "19 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Roan C Raymundo, BS",
                    "role": "CONTACT",
                    "phone": "(650) 721-4071",
                    "email": "rcraymun@stanford.edu"
                },
                {
                    "name": "Grace Yi",
                    "role": "CONTACT",
                    "phone": "650-723-1423",
                    "email": "gracesyi@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Judy Nguyen, MD",
                    "affiliation": "Stanford Cancer Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford Cancer Institute",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Roan C Raymundo, BS",
                            "role": "CONTACT",
                            "phone": "650-721-4071",
                            "email": "rcraymun@stanford.edu"
                        },
                        {
                            "name": "Grace Yi",
                            "role": "CONTACT",
                            "phone": "650-723-1423",
                            "email": "gracesyi@stanford.edu"
                        },
                        {
                            "name": "Judy Nguyen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Yu-Jin Lee, MD, MS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Andrei Iagaru, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Carina Aparici, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Guido Davidzon, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Farshad Moradi, MD, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Benjamin L Franc, MD, MS, MBA",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Jagruti Shah, MBBS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Saad Khan, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Dimitrios Colevas, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Fred Baik, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Chris Holsinger, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Vasu Divi, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Head and Neck Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077544",
                    "term": "Panitumumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21686",
                    "name": "Fluorodeoxyglucose F18",
                    "relevance": "LOW"
                },
                {
                    "id": "M1822",
                    "name": "Panitumumab",
                    "asFound": "Carotid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}